Duarte, CA, United States of America

Ravi Bhatia


Average Co-Inventor Count = 4.7

ph-index = 1


Location History:

  • Duarte, CA (US) (2013 - 2015)
  • Arcadia, CA (US) (2016)

Company Filing History:


Years Active: 2013-2016

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Inventor Ravi Bhatia

Introduction

Ravi Bhatia is a notable inventor based in Duarte, CA. He has made significant contributions to the field of medical research, particularly in the area of cancer treatment. With a total of 3 patents, his work focuses on improving patient outcomes through innovative methods and technologies.

Latest Patents

One of Ravi Bhatia's latest patents is titled "Gene signatures for prediction of therapy-related myelodysplasia and methods for identification of patients at risk for development of the same." This invention provides a gene expression signature for predicting the risk of developing therapy-related myelodysplasia or acute myeloid leukemia (t-MDS/AML) after autologous hematopoietic cell transplantation (aHCT). The method involves analyzing a biological sample containing CD34 cells from a subject and comparing gene expression levels to predict the risk of developing t-MDS/AML.

Another significant patent is the "Cell culture model for acquired chemoresistance of chronic myelogenous leukemia and related methods for identifying agents to overcome resistance." This patent outlines a method for generating a chronic myelogenous leukemia (CML) acquired chemoresistant culture model. It includes administering a mutation-inducing dose of imatinib to a naїve blast crisis CML cell line and determining the presence of a BCR-ABL mutation to confirm acquired chemoresistance.

Career Highlights

Ravi Bhatia has worked with esteemed institutions such as City of Hope and Fred Hutchinson Cancer Center. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include WenYong Chen and Leila Su. Their collaborative efforts have further advanced the research and development of innovative solutions in cancer treatment.

Conclusion

Ravi Bhatia's contributions to medical research through his patents and collaborations highlight his commitment to improving patient care and treatment outcomes. His innovative approaches continue to pave the way for advancements in cancer therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…